Self-Management and Recovery Technology Psychosocial Intervention Trial (SMARTTherapy)

September 14, 2017 updated by: Swinburne University of Technology

Psychosocial Intervention Using Online Resources to Promote Personal Recovery in Users of Specialist Mental Health Services

This project is a component of a broader research program referred to as "Self-Management and Recovery Technology (SMART): Use of online technology to promote self-management and recovery in people with psychosis", which has been funded by the Victorian Department of Health Mental Illness Research Fund (MIRF33). The overall research program is examining the therapeutic potential of using online (Internet-based) educational and multimedia resources in mental health services. It involves the development of a website which can be accessed via an internet browser on a desktop computer, tablet computer, or smartphone. It consists of a series of educational modules containing textual information, exercises, audio, and video clips designed to promote self-management and recovery in people with a history of persisting mental illness.

This particular project (SMART-Therapy) involves a randomised controlled trial examining the use of a discrete 8-session psychosocial intervention delivered in addition to routine care which utilises these online materials. The intervention will involve a mental health worker meeting with the participant with a tablet computer (e.g. iPad) on which online materials can be viewed, and used to guide an interaction with the participant.

The randomised controlled trial will include 148 participants, who will be randomised to receive one of two interventions: (a) meeting with a support worker using the SMART website to guide interaction (health intervention), or (b) meeting with a support worker delivering a social interaction-based control condition (social intervention). In each condition, there will be 8 x 50min face-to-face sessions over 3 months. Assessments will be completed pre-randomisation, and at 3, 6 and 9 months.

The primary hypothesis is that participants randomised to the health intervention will show greater improvement in personal recovery than participants randomised to the social intervention, and that these improvements will be maintained at follow-up (6 and 9 months following intake).

Study Overview

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Eastern Melbourne, Victoria, Australia
        • EACH
      • Eastern Melbourne, Victoria, Australia
        • Eastern Health
      • Fairfield, Victoria, Australia, 3078
        • Mental Illness Fellowship of Victoria
      • Fitzroy, Victoria, Australia, 3065
        • St Vincent's Health mental health services
      • Frankston, Victoria, Australia
        • Peninsula Health
      • Heidelberg, Victoria, Australia, 3084
        • Austin Health
      • Heidelberg, Victoria, Australia, 3084
        • Mind Australia
      • Melbourne, Victoria, Australia, 3004
        • Alfred Health mental health services
      • Melbourne, Victoria, Australia
        • Neami National
      • Melbourne, Victoria, Australia
        • North Western Mental Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. diagnosis of a functional psychotic disorder (schizophrenia-related disorder OR bipolar disorder or major depressive disorder with the presence of a severe episode with psychotic features within the past 2 years);
  2. sufficient fluency in English to make use of the resources;
  3. overall intellectual functioning within normal limits (WTAR estimated IQ>70);

Exclusion criteria (e) change in medication or in-patient admission in the previous 2 months;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health intervention
+ treatment as usual
Participants will receive 8 50-minute sessions during a 3 month window with a mental health worker, in addition to their routine care. Sessions will be structured by the worker and participant using a tablet computer to view materials on mental health self-management and personal recovery on a dedicated website for the trial. These will include information, videos, audio and exercises. Online materials make particular use of videos featuring people with lived experience of psychosis discussing how they have dealt with issues in their recovery, and will allow users to post comments on videos and in a forum. Participants may access online materials both during intervention sessions and outside sessions using any Internet-enabled device.
Active Comparator: Social intervention
+ treatment as usual
Participants will receive 8 50-minute sessions during a 3 month window with a mental health worker in addition to routine care (treatment as usual). The social intervention will utilise a computer tablet (i.e., iPad) servicing online resources to extend a manualised befriending intervention, based upon social interaction, designed to control for therapist contact and computer use. Each session will involve interaction about non-health related topics of interest to the participants, which will be facilitated by use of viewing online material related to these interests on a tablet computer as a prompt to conversation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Process of Recovery Questionnaire (QPR)
Time Frame: Baseline, 3, 6 and 9 months
Assesses personal recovery
Baseline, 3, 6 and 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Positive and Negative Syndrome Scales (PANSS)
Time Frame: Baseline, 3, 6 and 9 months
Assesses psychotic symptomatology
Baseline, 3, 6 and 9 months
Change in Subjective Experience of Psychosis Scale (SEPS)
Time Frame: Baseline, 3, 6 and 9 months
Assesses subjective impact of psychotic symptoms
Baseline, 3, 6 and 9 months
Change in Depression Anxiety Stress Scale (DASS-21)
Time Frame: Baseline, 3, 6 and 9 months
Assesses emotional symptoms
Baseline, 3, 6 and 9 months
Change in Assessment of Quality of Life 8dimension (AQol8d)
Time Frame: Baseline, 3, 6 and 9 months
Assesses quality of life
Baseline, 3, 6 and 9 months
Change in Resource Use Questionnaire
Time Frame: Baseline, 3, 6 and 9 months
Measure of health service use
Baseline, 3, 6 and 9 months

Other Outcome Measures

Outcome Measure
Time Frame
Change in Self-Efficacy for Personal Recovery Scale
Time Frame: Baseline, 3, 6 and 9 months
Baseline, 3, 6 and 9 months
Change in General Self-Efficacy Scale
Time Frame: Baseline, 3, 6 and 9 months
Baseline, 3, 6 and 9 months
Change in Schizophrenia Hope Scale
Time Frame: Baseline, 3, 6 and 9 months
Baseline, 3, 6 and 9 months
Change in UCLA Loneliness Scale
Time Frame: Baseline, 3, 6 and 9 months
Baseline, 3, 6 and 9 months
Change in Internalised Stigma of Mental Illness Scale
Time Frame: Baseline, 3, 6 and 9 months
Baseline, 3, 6 and 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

May 24, 2015

First Submitted That Met QC Criteria

June 12, 2015

First Posted (Estimate)

June 17, 2015

Study Record Updates

Last Update Posted (Actual)

September 15, 2017

Last Update Submitted That Met QC Criteria

September 14, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2014/119
  • MIRF33 (Other Grant/Funding Number: Victorian Department of Health Mental Illness Research Fund)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychotic Disorders

Clinical Trials on Health intervention

Subscribe